{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obesity Treatment: A Focus on Pharmacotherapy of Weight Management

Activity Steps

Description

This is a knowledge-based activity directed at the pharmacist. 0431-0000-20-002-H05-P To successful complete the activity the learner is expected to pass the post-test with a score of 77% and fill out the closing evaluation.
Accreditation Statement:
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Purpose of Activity

This activity provides information on pharmacologic agents approved by the Food & Drug Administration (FDA) for weight loss.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Summarize the recommended uses, pharmacokinetics, potential benefits, and safety concerns related to the use of FDA-approved pharmacologic agents for weight loss.
  2. Identify contraindications for and adverse effects of pharmacologic weight loss agents.
Price: $20.00

Credits:

  • ACPE 0.2 CEU

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. UAN 0431-0000-20-002-H05-P

Professions: Pharmacist
Test Code: ON0320D-Pharm
Published: Mar/Apr 2020
Expires: 7/31/2023
Required Passing Score: 19/24 (79%)
Authors: Khyati Patel, PharmD, BCACP
Assistant Professor, Department of Pharmacy Practice
Rosalind Franklin University of Medicine and Science, Chicago, IL.
Categories: Pharmacology
Topics: Weight